GoKawiilEfferon's pediatric sepsis blood filter wins CE mark, eyes FDA filing
Startup Efferon has developed a blood-purification device called Efferon NEO that absorbs both endotoxins and cytokines to treat pediatric sepsis, which kills about 3 million children under five each year. The device received CE mark approval in April, making it the first multimodal blood purification device built specifically for children, and is now used in ICUs across 30 countries including parts of Europe, Saudi Arabia, and Thailand. Efferon is preparing an FDA submission and expects to reach $2 million in annualized revenue by the end of 2026.